2019-2023 US Molecular Blood Typing, Grouping and Infectious Disease NAT Screening Market: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review, Opportunities for Suppliers

December 2018 | 465 pages | ID: U85F1A73224EN
Venture Planning Group

Abstracts

Complete report $9,700. DataPack (test volumes, sales forecasts, supplier shares) $6,300.


This comprehensive report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the US molecular blood banking market during the next five years, and assist industry executives in developing effective business, new product development and marketing strategies.

The report explores future marketing and technological trends in US; provides test volume and sales forecasts by market segment/test location; compares features of major automated and semi-automated analyzers; profiles leading and emerging competitors; and identifies specific product and market opportunities facing suppliers during the next five years.

Blood Group Genotyping

PCR, PCR-RFLP, AS-PCR or PCR-SSP, Multiplex PCR, Real Time PCR, Sanger DNA Sequencing, Pyrosequencing

Microarrays

BeadChip Array, BloodChip, Genome Lab SNP Stream, Fluidic Microarray Systems, TaqMan OpenArray, MALDI-TOF-MS, Mini-Sequencing

Blood Typing and Grouping Tests

ABO, Antibody Panels, Antibody Screening/Indirect Antiglobulin, Antigen Typing (C, c, Duffy, E, e, I, i, Kell, Kidd, Le a, b, MN, P, S, s), Antiglobulin (Direct, C3 + IgG, IgG, C3), Crossmatching (Immediate Spin, Full Crossmatch), Rh (D, Du).

Infectious Disease Screening Tests

AIDS (HIV NAT, HIV-1/2), Cytomegalovirus, Hepatitis (HAV NAT, HBV NAT, HBs Ag, Anti-HBc, HCV NAT, HCV, ALT/SGPT), HTLV-I/II, Parvovirus B19 NAT, Syphilis, West Nile Virus NAT

Sales and Market Share Analysis

Sales and market share estimates for leading suppliers of blood banking products by individual product.

Competitive Assessments

Strategic assessments of major suppliers and emerging market entrants, including their sales, product portfolios, marketing tactics, and new products in R&D.

Market Segmentation Analysis

• Comprehensive market segmentation analysis, including review of the market dynamics, trends, structure, size, growth, and key suppliers.
• Test volume and sales forecasts for over 40 blood typing, grouping and infectious disease screening tests, including NAT, by market segment:
• Blood Centers
• Plasma Fractionation Facilities
• Hospitals
• Commercial/Private Laboratories
• Military Blood Banks

Current and Emerging Products

• Analysis of current and emerging blood typing, grouping and infectious disease screening tests.
• Review of automated and semi-automated analyzers.

Technology Review

• Assessment of current and emerging technologies, and their potential applications for the blood banking market.
• Comprehensive lists of companies developing or marketing new technologies and products, by test.

Strategic Recommendations

• New product development opportunities with significant market appeal.
• Alternative market penetration strategies.
• Potential market entry barriers and risks.

Contains 465 pages and 48 tables

Contents

1. INTRODUCTION

2. WORLDWIDE TECHNOLOGY AND MARKET OVERVIEW

    a. Major Blood Typing, Grouping and Infectious Disease Screening Tests
  1. BLOOD TYPING AND GROUPING TESTS
    a. ABO
    b. Antibody Panels
    c. Antibody Screening
    d. Antigen Typing
    e. Antiglobulin Test
    f. Crossmatch
    g. HLA Typing
    h. Rh

1. OTHER BLOOD GROUPS

  2. BLOOD GROUP GENOTYPING
    a. PCR
    b. PCR  RFLP
    c. AS  PCR or PCR  SSP
    d. Multiplex PCR
    e. Real Time PCR
    f. Sanger DNA Sequencing
    g. Pyrosequencing
    b. Microarrays
  BeadChip Array
  BloodChip
  Genome Lab SNP Stream
  Fluidic Microarray Systems
  TaqMan OpenArray
  MALDiTOf MS
  MiniSequencing
  3. INFECTIOUS DISEASE SCREENING TESTS
    a. AIDS
  Structure and Composition
  Classification
  Origin of AIDS
  Animal Lentivirus Systems
  Virus Receptors
  HIV Infections in Humans
  Pathogenesis & Pathology
  Overview of Course of HIV Infection
  CD4T Lymphocytes and Memory Cells
  Monocytes and Macrophages
  Lymphoid Organs
  Neural Cells
  Viral Coinfections
  Clinical Findings
  Plasma Viral Load
  Pediactric AIDS
  Neurologic Disease
  Opportunistic Infections
  Protozoa
  Fungi
  Bacteria
  Viruses
  Cancer
  Immunity
  Laboratory Diagnosis
  Virus Isolation
  Serology
  Detection of Viral Nucleic Acid or Antigens
  Epidemiology
  Worldwide Spread of AIDS
  United States
  Routes of Transmission
  Prevention, Treatment, And Control
  Antiviral Drugs
  Vaccines Against HIV
  Transmission of HIV in Blood Products
  HIV Transmission in Transplant and Artificial Insemination Recipients
  Diagnostic Tests
  Enzyme Immunoassay Interpretation
  Specificity, Sensitivity, and Predictive Value of Enzyme Immunoassay
  Competition Assays
  Western Blot Technique
  Immuno Fluorescence Assay (IFA)
  Radioimmunoprecipitation
  HIV  1/HIV  2 Combination Testing
  Methods of HIV  Antigen Detection
  Antigen Assays and Blood Screening
  Urine Tests
  DNA Probes
  Overview
  Quantitative Polymerase Chain Reaction
  In Situ PCR
  Needed Improvements
  Viral Load/Drug Resistance Testing
  Genotype and Phenotype Testing
  Blood Banking Considerations
    b. Hepatitis
  Hepatitis A
  Hepatitis B
  Structure and Composition
  Replication of Hepatitis B Virus
  Hepatitis C
  Hepatitis D (Delta Hepatitis)
  Hepatitis E
  Hepatitis G
  Hepatitis Virus Infections In Humans
  Pathology
  Clinical Findings
  Laboratory Features
  Hepatitis A
  Hepatitis B
  Hepatitis C
  Hepatitis D
  Hepatitis E
  Virus  Host Immune Reactions
  Epidemiology
  Hepatitis A
  Hepatitis B
  Hepatitis C
  Hepatitis D (Delta Agent)
  Vaccines and Drugs
    c. Cytomegalovirus
  Background
  Chorioretinitis
  Gastrointestinal
  Central Nervous System Disease
  Diagnostic Tests
  Vaccines and Drugs
    d. Syphilis
  Background
  Diagnostic Tests
  Vaccines and Drugs
    e. West Nile Virus
  Background
  Clinical Syndromes
  Diagnostic Tests
  Vaccines and Drugs
    f. Parvovirus B19
  Microbiology
  Epidemiology
  Clinical Syndromes
  Erythema Infectiosum Slapped (cheek)
  Adult Polyarthropathy
  Transient Aplastic Crisis
  Transient Pancytopenia
  Red Cell Aplasia in the Immunocompromised
  Perinatal Infections
  Diagnosis
  Treatment
    g. Creutzfeldt  Jakob’s Disease
  Background
  Transmission
  Diagnostic Tests
  Major Commercial and Academic Players
  Bayer
  Disease Sciences/BioTec Global
  Imperial College School of Medicine
  Ortho Clinical Diagnostics
  Pall
  ProMetic Life Sciences
  Proteome Sciences/Idexx
  Q  One Biotech
  Serono
  U.S. Agricultural Research Service
  Drugs
  Vaccines
    h. Malaria

1. CHAGAS DISEASE

j. Babesiosis
  4. PATHOGEN REDUCTION
  5. LEUKOCYTE REDUCTION
  Background
  Methods
    b. INSTRUMENTATION Review: Operating Characteristics, Features and Selling Prices of Leading Automated and Semiautomated Analyzers Manufactured by:
  Abbott
  Beckman Coulter/Danaher
  Becton Dickinson
  Bio Rad
  BioMerieux
  Cepheid
  Curtis Unyvero
  GenProbe/Hologic
  GenMark
  Grifols
  HTG
  Immucor
  Life Technologies
  Nanosphere
  Ortho Clinical Diagnostics
  Qiagen
  Roche
  Sarstedt
  Siemens
  Tecan
    c. Major in Vitr      Diagnostic Technologies and Their Potential Applications
  1. MOLECULAR DIAGNOSTICS
    a. Overview
    b. NAT
  2. MONOCLONAL AND POLYCLONAL ANTIBODIES
  3. IMMUNOASSAYS
    a. Technological Principle
    b. Chemiluminescence
    c. Enzyme Immunoassays (EIA)
  Overview
  ELISA
  EMIT
  Electrochemical
    d. Radioimmunoassays (RIA)
    e. Immunoprecipitation
    f. Affinity Chromatography
  4. MICROTITRATION PLATES
  5. IT AND AUTOMATION
  6. LASERS
  7. ROBOTICS
  8. SYNTHETIC RED CELL SUBSTITUTES
  9. GENETICALLY ENGINEERED BLOOD COMPONENTS
    a. Albumin
    b. Factor VIII
    c. Alpha  2 Antiplasmin
    d. Antithrombin III
    e. Factor IX
    f. Von Willebrand's Factor
    g. Fibrinogen
    h. t  PA
  10. BLOOD PRESERVATION
  11. AUTOLOGOUS BLOOD TRANSFUSION/FREEZING

3. U.S.

    a. EXECUTIVE SUMMARY

    b. Business Environment
    c. Market Structure
    d. Market Size, Growth and Major Supplier Sales and Market Shares for Blood Typing, Grouping and Infectious Disease Screening Tests

4. MAJOR PRODUCT DEVELOPMENT OPPORTUNITIES

    a. Molecular Blood Typing and Grouping
    b. Infectious Disease Screening
    c. Auxiliary

5. ALTERNATIVE MARKET PENETRATION STRATEGIES

    a. Internal Development
    b. Collaborative Arrangements
    c. University Contracts

6. POTENTIAL MARKET ENTRY BARRIERS AND RISKS

    a. Market Maturity
    b. Cost Containment
    c. Competition
    d. Technological Edge and Limitations
    e. Patent Protection

7. COMPETITIVE ASSESSMENTS

  Abbott
  Beckman Coulter/Danaher
  Becton Dickinson
  Biokit
  BioMerieux
  Bio Rad
  CellMark Forensics/LabCorp
  Diagast
  DiaSorin
  Fujirebio
  Hologic/GenProbe
  Grifols
  Immucor
  Ortho Clinical Diagnostics
  Proteome Sciences
  Quest Diagnostics
  Quidel
  Roche
  Siemens
  Tecan
  ThermFisher
Major Companies Developing or Marketing Blood Typing and Grouping Tests
Major Companies Developing or Marketing HLA Typing Tests
Major Companies Developing or Marketing AIDS Tests
Major Companies Developing or Marketing Hepatitis Tests
Major Companies Developing or Marketing CMV Tests
Major Companies Developing or Marketing Syphilis Tests
Major Companies Developing or Marketing Blood Bank Analyzers
EXECUTIVE SUMMARY Table: U.S.A., Total Blood Bank Test Volume and Reagent Sales Forecast by Test Category
U.S.A., Estimated Number of Inpatient and Ambulatory Surgeries
U.S.A., Facilities Performing Blood Bank Tests by Market Segment
U.S.A., Hospital Laboratories Performing Blood Bank Tests by Bed Size
U.S.A., Commercial/Private Laboratories Performing Blood Bank Tests by Annual Test Volume Forecast
U.S.A., Facilities Collecting Whole Blood and Plasma by Market Forecast Segment
U.S.A., Whole Blood and Plasma Collections by Market Forecast Segment
U.S.A., All Market Segments Blood Typing and Grouping Test Volume by Market Forecast Segment
U.S.A., All Market Segments Blood Typing and Grouping Test Volume Forecast
U.S.A., Hospital Laboratories Blood Typing and Grouping Test Volume Forecast
U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Test Volume Forecast
U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Test Volume Forecast
U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Test Volume Forecast
U.S.A., Military Blood Banks Blood Typing and Grouping Test Volume Forecast
U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast by Market Segment
U.S.A., All Market Segments Infectious Disease Screening Test Volume Forecast
U.S.A., Community and Regional Centers Infectious Disease Screening Test Volume Forecast
U.S.A., Plasma Fractionation Centers Infectious Disease Screening Test Volume Forecast
U.S.A., Hospital Blood Banks Infectious Disease Screening Test Volume Forecast
U.S.A., Military Blood Banks Infectious Disease Screening Test Volume Forecast
U.S.A., All Market Segments Blood Typing and Grouping Reagent Market Forecast by Market Segment
U.S.A., All Market Segments Blood Typing and Grouping Reagent Market Forecast by Market Segment
U.S.A., Hospital Blood Banks Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., Community and Regional Blood Centers Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., Commercial/Private Laboratories Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., Plasma Fractionation Centers Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., Military Blood Banks Blood Typing and Grouping Reagent Market Forecast by Major Test
U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
U.S.A., All Market Segments Infectious Disease Screening Reagent Market by Market Forecast Segment
U.S.A., Community and Regional Centers Infectious Disease Screening Reagent Market Forecast by Test
U.S.A., Plasma Fractionation Centers Infectious Disease Screening Reagent Market Forecast by Test
U.S.A., Hospital Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
U.S.A., Military Blood Banks Infectious Disease Screening Reagent Market Forecast by Test
U.S.A., Major Suppliers of Blood Typing and Grouping Reagents Estimated Sales and Market Shares
U.S.A., HIV/HTLV Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., Hepatitis Blood Screening Market, Reagents Sales by Major Supplier
U.S.A., Hepatitis C Blood Screening Market, Reagent Sales By Major Supplier
U.S.A., HIV/Hepatitis C NAT Market, Reagent Sales By Major Supplier
U.S.A., West Nile Virus NAT Market, Reagent Sales by Major Supplier
U.S.A., CMV Blood Screening Market, Reagent Sales by Major Supplier
U.S.A., Syphilis Blood Screening Market, Reagent Sales by Major Supplier